Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 50 out of 100. Treatments

Topic: Risk, prevention and care in population studies

Introduction The purpose of this research was to assess effects of a mindfulness based neuropsychological intervention on the clinical course of Alzheimer's disease. Material and method A two year randomized and double blind clinical trial was conducted on 127 probable Alzheimer's disease patients, according to NINCDS-ADRDA scale. Patients were grouped into three experimental groups (cognitive stimulation, progressive muscular relaxation, and mindfulness) plus a control group. All participants were receiving donepezil. Cognitive skills were assessed with CAMCOG and MMSE, functional area with RDRS-2, and NPI was used for psychopathology screening. Three treatment sessions per week were carried out for two years, and follow up measurements were taken every six months. Results The global cognitive function, functionality and behavioral disorders measurements indicated that patients from the experimental group based on mindfulness were stable during the two years, while patients from the control group, as well as the other experimental groups, showed a mild but significant worsening of their mental capacities. Conclusion The mindfulness based neuropsychological program showed better cognitive and functional stability, as well as significant improvement in the psychopathological condition of mild to moderate Alzheimer' patients. These results support the idea that a mindfulness based intervention can produce a clinically relevant improvement in the treatment of dementia. More research is needed to confirm these data.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Quintana Hernández, D. J., Miró Barrachina, M. T., Ibáñez Fernández, I., del Pino, A. S., Rodríguez, G., Jr., & Hernández, JR. (2014). [Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study]. Revista espanola de geriatria y gerontologia. https://doi.org/10.1016/j.regg.2014.03.002

Vancouver

Quintana Hernández DJ, Miró Barrachina MT, Ibáñez Fernández I, del Pino AS, Rodríguez G Jr, Hernández JR. [Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study]. Revista espanola de geriatria y gerontologia. 2014. doi:10.1016/j.regg.2014.03.002. PMID: 24880524.

BibTeX

@article{quintanahernandez2014-24880524,
  author  = {Quintana Hernández, D. J. and Miró Barrachina, M. T. and Ibáñez Fernández, I. and del Pino, A. S. and Rodríguez, Jr., García and Hernández, JR.},
  title   = {{[Effects of a neuropsychology program based on mindfulness on Alzheimer's disease: randomized double-blind clinical study]}},
  journal = {Revista espanola de geriatria y gerontologia},
  year    = {2014},
  doi     = {10.1016/j.regg.2014.03.002},
  pmid    = {24880524},
  url     = {https://doi.org/10.1016/j.regg.2014.03.002}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In this two-year trial of 127 patients with probable Alzheimer's disease, those receiving a mindfulness-based program remained stable on cognition, function, and behavior, while the control and other experimental groups worsened mildly. The authors conclude the program supported cognitive and functional stability in mild to moderate disease.

Study details

How this study scored 50/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 11 of 12; Strength of evidence 5 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 2 of 2; Times cited 3 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 1 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 50 of 100.50 of 100 points earned50 not earned

Published in a peer-reviewed journal, and it is a randomised controlled trial. Scored zero for sample size and effect reported because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Revista espanola de geriatria y gerontologia)
Journal's citation record 0 / 4 Revista Española de Geriatría y Gerontología: journal h-index 38 (OpenAlex, 2026-10-29)
Study design 11 / 12 A randomised controlled trial (from PubMed type “Randomized Controlled Trial”)
Strength of evidence 5 / 5 Rated “high” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2014 — within 20 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (pubmed indexes it as a clinical or observational study)
Randomised / blinded 2 / 2 Randomised and blinded or placebo-controlled (as stated in the record)
Times cited 3 / 7 Cited 16 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.1 citations a year over 14 year(s) since 2014
Impact for its field and year 2 / 6 Cited 2.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 2 other studies in this library
Still being cited 0 / 4 Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Jaime Rojas‐Hernández: h-index 8 (OpenAlex, whole career)
Institution's track record 0 / 3 Universidad de La Laguna: institution h-index 471 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 24880524)
Free to read 0 / 2 Behind a paywall — scores zero
Total 50 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription Unpaywall, Europe PMC and OpenAlex found no free copy of the full text (checked 10 Oct 2026), so the publisher may charge for it. The PubMed abstract is free.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

2 studies in the alzhub library list this one in their references.

Related studies in Treatments

Also tagged “double-blind”

783 studies in the library carry the topic tag “double-blind”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.

Similar studies

More on Treatments

See all studies in Treatments →